Burosumab: EMA Updates Hypercalcemia Monitoring Guidance



Updated surveillance protocols target severe hypercalcemia risk in patients receiving burosumab for X-linked hypophosphatemia treatment.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/burosumab-ema-updates-hypercalcemia-monitoring-guidance-2025a1000njk?src=rss

Author :

Publish date : 2025-09-05 14:51:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version